Exelixis tops Q1 earnings and revenue estimates
Exelixis Inc. (NASDAQ: EXEL) surpassed Q1 earnings and revenue projections. The company reported earnings of $0.27 per share on revenue...
Health Care
Acorda Therapeutics stock sinks to 13-year low
Acorda Therapeutics (NASDAQ: ACOR) stock tumbled to a 13-year low of $10.02 on Wednesday as investors remained concerned about the...
Novavax Q1 earnings preview: Future plans on ResVax and NanoFlu will be the key focus points
Novavax Inc (NASDAQ: NVAX) is slated to report its first quarter 2019 earnings results after market closes on Thursday. Novavax...
Earnings preview: New product launches in focus as Teva gets ready for Q1 report
Teva Pharmaceutical (NYSE: TEVA) has long endued uncertainties in business even as the generic drug maker continued its efforts to...
Gilead Sciences earnings preview: What to expect in Q1
Gilead Sciences (NASDAQ: GILD) has tested its investors enough lately. The stock has increased just 2.5% in the year-to-date period,...
CVS Health posts upbeat Q1 earnings, Q2 forecast
CVS Health Corporation (NYSE: CVS) reported a 43% jump in earnings for the first quarter of 2019 helped by the...
Earnings: Humana Q1 profit climbs on strength of Medicare biz; lifts FY19 guidance
Healthcare service provider Humana, Inc. (NYSE: HUM) Wednesday reported better than expected earnings and revenues for the first quarter, helped...
Amarin Corp tops the market in Q1 on Vascepa strength
Amarin Corporation (NASDAQ: AMRN) on Wednesday said its revenues soared 67% to $73.3 million, riding on the strong demand for...
Vertex Pharmaceuticals’ Q1 results beat estimates
Vertex Pharmaceuticals (NASDAQ: VRTX) topped market expectations on revenue and earnings for the first quarter of 2019. Shares were up...
Amgen Q1 earnings beat Street view; lifts full-year earnings guidance
Biotechnology firm Amgen (Nasdaq: AMGN) reported first-quarter earnings that increased from last year and exceeded estimates, while revenues remained unchanged. Meanwhile,...
Pfizer Q1 profit tops expectations; raises FY19 earnings outlook
Pharma giant Pfizer (NYSE: PFE) Tuesday reported stronger than expected earnings and revenues for the first quarter of 2019. The...
KEYTRUDA helps Merck to report Q1 earnings beat, raises 2019 outlook
Shares of the pharma giant Merck (MRK) rose 2% before the market hours after the company surpassed estimates on the...
Eli Lilly’s stock down after Q1 revenues miss forecasts
Eli Lilly and Company (NYSE: LLY) surpassed analysts’ expectations on earnings for the first quarter of 2019 while revenues fell...
Earnings preview: What to expect when Amgen reports Q1 2019 results
Amgen Inc. (NASDAQ: AMGN) is scheduled to report first-quarter 2019 earnings results on Tuesday, April 30, after market close. Analysts...
Amarin earnings preview: Expect higher revenues, but wider losses in Q1
Amarin Corporation (NASDAQ: AMRN) is scheduled to report first-quarter 2019 earnings results on Wednesday, May 1, before the opening bell. Analysts...
Cancer drugs boost AstraZeneca results in Q1
Riding on the strong demand for its cancer drugs, AstraZeneca Plc (NYSE: AZN) on Friday reported its third consecutive quarter...
Bristol-Myers Squibb tops Q1 estimates, gets shareholder approval for Celgene acquisition
Biopharma company Bristol-Myers Squibb (NYSE: BMY) on Thursday reported better-than-expected first-quarter 2019 results, sending its shares up over 1% during...
AbbVie’s stock gains after Q1 results top expectations
AbbVie Inc. (NYSE: ABBV) surpassed market estimates on revenue and earnings for the first quarter of 2019, giving shares a...
Boston Scientific stock falls as Q1 earnings and sales missed consensus estimates
Boston Scientific (NYSE: BSX) reported first quarter 2019 earnings results before the market opened today. The medical technology company’s earnings...
Spinraza helps Biogen beat the street in Q1
A month after announcing the withdrawal from its Phase 3 Alzheimer’s trials, biopharma firm Biogen (NASDAQ: BIIB) on Wednesday reported...
Intuitive Surgical (ISRG) posts Q1 2019 earnings
Sunnyvale-based Intuitive Surgical (ISRG) posted its first-quarter 2019 earnings after the closing bell on April 18. Minimally invasive surgery leader...